Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PharmaKinetics Labs

Executive Summary

Baltimore-based contract lab names V. Brewster Jones as president of PharmaKinetics U.S.A. under a management reorganization announced April 25. For the last five years, Jones has been president of Compucare, a contract healthcare facilities and data management firm. He reports to PharmaKinetics Labs President and CEO Steve Woodman. Reporting to Woodman are Glenn McAvoy, who has been promoted to VP and chief financial officer, from corporate comptroller, and Christopher Holloway, managing director of PharmaKinetics' wholly owned West German subsidiary International Bio Research (IBR), which was acquired by PharmaKinetics in July 1989. McAvoy succeeds Thomas Rice who is leaving to start a financial consulting service, the company said.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017353

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel